Dr. Bashir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Unit 423
Houston, TX 77030Phone+1 713-794-5745Fax+1 713-794-4902- Is this information wrong?
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 2006 - 2009
- University of Missouri-ColumbiaResidency, Internal Medicine, 2003 - 2006
- King Edward Medical UniversityClass of 2001
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2009 - 2025
- TN State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- AZ State Medical License 2023 - 2025
- WA State Medical License 2023 - 2024
- AL State Medical License 2023 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT) Start of enrollment: 2014 Jan 01
- Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation Start of enrollment: 2019 Oct 09
Publications & Presentations
PubMed
- Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.Sairah Ahmed, Qaiser Bashir, Roland L Bassett Jr, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa Khouri, David Marin, ...> ;American Journal of Hematology. 2024 Apr 1
- Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies.Supawee Saengboon, Julianne Chen, Gabriela Rondon, Jim S Im, Elizabeth J Shpall, Stefan O Ciurea, Uday R Popat, Jeremy Leon Ramdial, Qaiser Bashir, Amin Majid Alousi, ...> ;Blood Advances. 2024 Mar 23
- Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation.Curtis Marcoux, Rima M Saliba, Whitney Wallis, Sajad Khazal, Dristhi Ragoonanan, Gabriela Rondon, Priti Tewari, Uday Popat, Betul Oran, Amanda Olson, Qaiser Bashir, Mu...> ;Blood Advances. 2024 Mar 12
- Join now to see all
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
- Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature
Press Mentions
- Busulfan Added to Conditioning Regimen Effective for Newly Diagnosed MyelomaMay 20th, 2019
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: